Erythropoietin changes contractility, cAMP, and nitrite levels of isolated rat hearts

被引:14
|
作者
Kaygisiz, Ziya [1 ]
Erkasap, Nilufer
Yazihan, Nuray
Sayar, Kemal
Ataoglu, Haluk
Uyar, Run
Ikizler, Murat
机构
[1] Eskiehir Osmangazi Univ, Fac Med, Dept Physiol, TR-26480 Eskisehir, Turkey
[2] Eskiehir Osmangazi Univ, Fac Med, Dept Cardiovasc Surg, TR-26480 Eskisehir, Turkey
[3] Ankara Univ, Fac Med, Physiopathol Unit, TR-06100 Ankara, Turkey
[4] Ankara Univ, Fac Med, Pharmacol Unit, TR-06100 Ankara, Turkey
[5] Ankara Univ, Microbiol Unit, Mol Biol Res & Dev Unit, TR-06100 Ankara, Turkey
来源
JOURNAL OF PHYSIOLOGICAL SCIENCES | 2006年 / 56卷 / 03期
关键词
erythropoietin; heart; contractility; cAMP; nitrite;
D O I
10.2170/physiolsci.RP004806
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
There is enough evidence that erythropoietin (EPO) may be involved in cardiovascular function. Therefore we have investigated the possible effects of EPO on left ventricular developed pressure, +dP/dt(max), heart rate, tissue cAMP, and nitrite levels. Isolated rat hearts were perfused under constant flow (10 ml/min) conditions with modified Krebs-Henseleit solution and. recombinant human erythropoietin at doses of 100, 200, 500, and 1,000 IU/kg was administered as bolus injections. EPO at 100 IU/kg decreased, but higher doses (500 and 1,000 IU/kg) raised the developed pressure and +dP/dt(max). However, it did not affect heart rate or coronary perfusion pressure when all the respective doses were applied. EPO at 100 IU/kg increased nitrite, and at 1,000 IU/kg it raised cAMP. Our results suggest that EPO may produce dose-dependently negative and positive inotropic effects on myocardial contractility in isolated rat hearts. NO and cAMP may be involved in negative and positive inotropic effects of EPO, respectively.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [21] DISSOCIATION OF CAMP CHANGES AND MYOCARDIAL-CONTRACTILITY IN TAURINE PERFUSED RAT-HEART
    SCHAFFER, SW
    CHOVAN, JP
    WERKMAN, RF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 81 (01) : 248 - 253
  • [22] RELATIONSHIP BETWEEN CAMP LEVELS AND PERMEABILITY ALBUMIN IN ISOLATED RAT MESENTERY
    KAHN, A
    BRACHET, E
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1976, 170 (01): : 227 - 230
  • [23] ACTION OF SYNTHETIC ATRIAL-NATRIURETIC-FACTOR ON CONTRACTILITY AND CORONARY PERFUSION IN ISOLATED WORKING RAT HEARTS
    HUTTER, JF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (01) : 127 - 129
  • [24] P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts
    Mei, QB
    Liang, BT
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (01): : H334 - H341
  • [25] FREE-RADICALS ALTER HIGH-ENERGY PHOSPHATES AND CONTRACTILITY IN ISOLATED PERFUSED RAT HEARTS
    BURTON, KP
    JONES, JG
    FASEB JOURNAL, 1992, 6 (04): : A1341 - A1341
  • [26] DEVELOPMENTAL-CHANGES IN MODULATION OF CONTRACTILITY OF RABBIT HEARTS
    AKITA, T
    KUMAR, R
    JOYNER, RW
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (02) : 240 - 251
  • [27] The modulation of pacing induced changes in intracellular sodium levels by extracellular Ca2+ in isolated perfused rat hearts
    Simor, T
    Lorand, T
    Gaszner, B
    Elgavish, GA
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (04) : 1225 - 1235
  • [28] Dissociation of negative inotropic effect of carbachol from changes in cAMP and PKA in perfused rat hearts
    Zhang, JZ
    MacLeod, KM
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (02): : H404 - H409
  • [29] Atenolol and fentanyl effects upon the heart rate, myocardial contractility, and coronary flow in isolated rat hearts.
    Maués, HK
    Pádua, WC
    Faraj, M
    Neves, HJ
    Gomes, ES
    Gomes, OM
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A75 - A75
  • [30] N(G)-METHYL-L-ARGININE DECREASES CONTRACTILITY, CGMP AND CAMP IN ISOPROTERENOL-STIMULATED RAT HEARTS INVITRO
    KLABUNDE, RE
    KIMBER, ND
    KUK, JE
    HELGREN, MC
    FORSTERMANN, U
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 223 (01) : 1 - 7